723 related articles for article (PubMed ID: 17415139)
1. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
Westerlaken BO; de Kleine E; van der Laan B; Albers F
Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
Battaglia A; Burchette R; Cueva R
Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss.
Cvorović L; Deric D; Probst R; Hegemann S
Otol Neurotol; 2008 Jun; 29(4):464-9. PubMed ID: 18434930
[TBL] [Abstract][Full Text] [Related]
6. Audiological evaluation of twenty patients receiving pentoxifylline and prednisone after sudden deafness: prospective study.
de Barros FA; Penido NO; Ramos HV; Sanchez ML; Fukuda Y
Int Tinnitus J; 2003; 9(1):17-22. PubMed ID: 14763324
[TBL] [Abstract][Full Text] [Related]
7. Recurrent sudden sensorineural hearing loss sensitive to transtympanic and systemic steroid treatment: case report.
Scapa VI; Friedland DR
Ear Nose Throat J; 2009 Mar; 88(3):E14-9. PubMed ID: 19291620
[TBL] [Abstract][Full Text] [Related]
8. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?
Ahn JH; Yoo MH; Yoon TH; Chung JW
Laryngoscope; 2008 Feb; 118(2):279-82. PubMed ID: 17989574
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
11. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial.
Westerlaken BO; Stokroos RJ; Dhooge IJ; Wit HP; Albers FW
Ann Otol Rhinol Laryngol; 2003 Nov; 112(11):993-1000. PubMed ID: 14653370
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
Plaza G; Herráiz C
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.
Choung YH; Park K; Shin YR; Cho MJ
Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082
[TBL] [Abstract][Full Text] [Related]
14. Local hypothermia in the treatment of idiopathic sudden sensorineural hearing loss.
Hato N; Hyodo J; Takeda S; Takagi D; Okada M; Hakuba N; Gyo K
Auris Nasus Larynx; 2010 Oct; 37(5):626-30. PubMed ID: 20167446
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
Kiliç R; Safak MA; Oğuz H; Kargin S; Demirci M; Samim E; Ozlüoğlu LN
Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss.
Egli Gallo D; Khojasteh E; Gloor M; Hegemann SC
Audiol Neurootol; 2013; 18(3):161-70. PubMed ID: 23446332
[TBL] [Abstract][Full Text] [Related]
17. Randomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss.
Ragab A; Shreef E; Behiry E; Zalat S; Noaman M
J Laryngol Otol; 2009 Jan; 123(1):54-60. PubMed ID: 18925995
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
[TBL] [Abstract][Full Text] [Related]
19. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
Klemm E; Bepperling F; Burschka MA; Mösges R;
Otol Neurotol; 2007 Feb; 28(2):157-70. PubMed ID: 17255882
[TBL] [Abstract][Full Text] [Related]
20. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL.
Hong SM; Park CH; Lee JH
Otolaryngol Head Neck Surg; 2009 Nov; 141(5):579-83. PubMed ID: 19861194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
